|
| Status |
Public on Nov 09, 2022 |
| Title |
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Methylation profiling by genome tiling array
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
36368321 |
| |
| Submission date |
Oct 04, 2022 |
| Last update date |
Feb 08, 2023 |
| Contact name |
Sheila Singh |
| E-mail(s) |
ssingh@mcmaster.ca
|
| Organization name |
McMaster University
|
| Department |
Biochemistry and Biomedical Sciences
|
| Street address |
1280 Main Street West
|
| City |
Hamilton |
| State/province |
ON |
| ZIP/Postal code |
L8S4K1 |
| Country |
Canada |
| |
|
| Platforms (3) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
| GPL21145 |
Infinium MethylationEPIC |
|
| Samples (18)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE214801 |
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma [RNA-seq] |
| GSE214802 |
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma [EPIC] |
| GSE214956 |
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma. [CRISPRseq] |
|
| Relations |
| BioProject |
PRJNA887081 |
Less...
More...